Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Regenerative Medicine: Key Developments in Regulation and Commercialization 

 

Regenerative Medicine: Key Developments in Regulation and Commercialization

ARM is a proud partner of the Food and Drug Law Institute’s Regenerative Medicine: Key Developments in Regulation & Commercialization conference. This meeting will take place in both Washington D.C. and San Francisco, CA on June 27, 2012. Regenerative Medicine Forum Newsletter subscribers may register for this must-attend event, and receive a 15% discount, by using the promotional code: REGENMED2012.
More information

 

Posted on 8-Jun-12 by Toto, Brent
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: